Matt S Zinter, Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo-Subait, Akshay Sharma, Amer Beitinjaneh, Dimana Dimitrova, Gregory Guilcher, Jaime M Preussler, Kasiani C Myers, Neel S Bhatt, Olle Ringden, Peiman Hematti, Robert J Hayashi, Sagar S Patel, Satiro De Oliveira, Seth J Rotz, Sherif M Badawy, Taiga Nishihori, David K Buchbinder, Betty K Hamilton, Bipin N Savani, Hélène M Schoemans, Mohamed Lotfy Sorror, Lena E Winestone, Christine Duncan, Rachel Phelan, Christopher C Dvorak
Allogeneic hematopoietic cell transplantation (HCT) can be complicated by life-threatening organ toxicity and infection necessitating intensive care. Epidemiologic data have been limited by single-center studies, poor database granularity, and a lack of long-term survivors. To identify contemporary trends in ICU utilization and long-term outcomes, we merged data from the Center for International Blood and Marrow Transplant Research and the Virtual Pediatric Systems databases. We identified 6,995 pediatric HCT patients age ≤21 years who underwent 1st allogeneic HCT between 2008-2014 across 69 centers in the United States or Canada and followed patients until the year 2020...
December 21, 2023: Blood Advances